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Tract-based spatial statistics (TBSS)DTI studies in multiple sclerosis (MS) reveal white matter (WM) injury that occurs with disease progression. In
the present studywe aimed to elucidate the relationship ofmicrostructuralWMdamage in patients with varying
periods of disease duration. DTI scans were acquired from 90MS patients and 25 healthy controls. Patients were
grouped to short (b1 year),moderate (1 up to 6 years) and long (6–10 years) disease duration periods. Statistical
analyses of the fractional anisotropy (FA) datawere performed using tract-based spatial statistics (TBSS).Whole-
brain skeletal FA measurements showed a signiﬁcant decrease between healthy controls and the short MS dis-
ease duration group, as well as between moderate disease duration and long disease duration groups, but failed
to show a signiﬁcant difference between short and moderate disease duration groups.
Voxelwise analysis revealed clusters of diffuse FA reductions in 40WM tracts when comparing healthy controls
and MS short disease duration group, with the point of maximal signiﬁcant difference located in the left inferior
longitudinal fasciculus.
Comparing short with long disease duration groups, progressive FA reduction was demonstrated across 30WM
tracts, with the point ofmaximal signiﬁcant differencemigrating to the body of the corpus callosum. A non-linear
pattern ofWMmicrostructure disruption occurs in RRMS. Alterations are seen early in the disease course within
1 year from onset, reach a plateauwithin the next 5 years, and only later additionalWMchanges are detected. An
important period of a possible therapeutic window therefore exists within the early disease stage.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
White matter (WM) injury is the cardinal pathological process oc-
curring early in multiple sclerosis (MS). Disruptions of WM tracts are
signiﬁcant predictors for physical disability and cognitive impairment
in MS, and hence are important to be quantiﬁed at different stages of
the disease course (Samann et al., 2012). WM damage can be detected
andmeasured by brainmagnetic resonance imaging (MRI), which dem-
onstrates focal and macroscopic inﬂammatory lesions by T2 and FLAIR
as well as axonal loss by T1 black holes. However, injuries outside
these lesions are not easily detected by conventional MRI techniques.
Therefore, there is a need to apply innovativemethods thatmay provide
additional insight into the ongoing pathological processes. Diffusiontter; FA, fractional anisotropy;
ility status scale; RRMS, relaps-
drome; ILF, inferior longitudinal
r, Sheba Medical Center, Tel-
5076.
. This is an open access article undertensor imaging (DTI) is a nonconventional MRI technique that is sensi-
tive to themagnitude anddirection ofwater diffusionwithin tissues and
therefore can provide integrity assessment and measurements of WM
tract damage even in the presumed normal appearing WM (Giorgio
et al., 2010).
DTI allows for calculation of the fractional anisotropy (FA),which is a
quantitative parameter for evaluating the direction-dependent diffusiv-
ity of water molecules along theWM tracts. FA ranges from 0 to 1 and is
an indirectmarker forWMintegrity, as decreased FA reﬂects greater de-
myelination of ﬁbers (Commowick et al., 2008; Roosendaal et al., 2009).
This is in accordance with a pathological study demonstrating that FA is
affected by myelin content in post-mortemMS brains (Schmierer et al.,
2007). Aligning FA data from multiple subjects can be performed
by tract-based spatial statistics (TBSS), an automated observer-
independent method. TBSS allows group-wise comparisons of DTI
data by analyzing it in a voxel-wise fashion and minimizes registration
errors, and is an advantageous approach as it enables that maximal FA
values for each subject will be directly compared at each point even if
the ﬁber centers are not perfectly aligned (Smith et al., 2007). TBSS
has already been validated as an effective way to evaluate the FA inthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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with clinically isolated syndrome (CIS), RRMS and primary progressive
MS (Bodini et al., 2009; Raz et al., 2010a; Roosendaal et al., 2009). The
signiﬁcance of TBSS analysis of DTI data from MS patients was
established by studies that demonstrated that decreased FA correlated
with increased disability by EDSS (Liu et al., 2012), lower cognitive per-
formance and speciﬁcally for processing speed, visual and verbal work-
ingmemory (Yu et al., 2012b). However, TBSS studies assessing patients
at different stages of disease course are scarce. Therefore, the aim of the
present studywas to investigate how changes inWMtracts relate toMS
disease duration, as clarifying this relationship could give better insight
on the microstructure changes that occur at different stages of the dis-
ease course. To this end, we investigated how structural WM disrup-
tions based on fractional anisotropy (FA) data and tract-based spatial
statistics (TBSS) analysis were affected by MS disease duration within
a cross-sectional study design in MS patients with short, moderate
and long disease duration periods.Weﬁrst investigated the relationship
ofwhole-brain skeletal FAmeasurements between healthy subjects and
MS patients with short disease duration of up to 1 year fromonset aswe
hypothesized that disruption of WM tracts will be identiﬁed already at
the this early disease stage. Further analyses were performed grouping
patients by 5 year intervals to moderate (from 1 year and up to 6 years
duration) and long (from 6 to 10 years inclusive) disease duration pe-
riods to assess the implications of WM disruption as the disease pro-
gresses. In addition, we performed voxelwise analysis to recognize
clusters of FA reductions in various WM tracts and to identify associa-
tions between regional WM changes that are detected in the early
phase ofMS and if these are similar in pattern in patientswithmoderate
and long disease duration periods.2. Materials and methods
2.1. Study design
Retrospective, cross-sectional in a tertiary referral center.2.2. Subjects
In total,MRI data obtained from100MSpatients and 30healthy sub-
jects were analyzed. Data from some subjects were excluded from anal-
yses because of neurological comorbidity (N= 7), toomany artifacts or
noise in the raw MRI data (N = 4), or absence of complete MRI data
(N = 4).
Consequently, 90 MS patients and 25 healthy subjects remained in
the study. All MS subjects met McDonald diagnostic criteria (Polman
et al., 2011) and were recruited from the MS database registry at the
Sheba MS Center, Tel-Hashomer. Enrolled patients fulﬁlled the follow-
ing inclusion criteria: (1) Age above 18 years; (2) RRMS disease course;
(3) MRI examination performed on 3.0 T including DTI protocol; (4) no
relapse or corticosteroid use within 4 weeks before study entry to avoid
transient confounding effects onMRI; and (5) absence of anothermajor
medical disorder. Clinically stable patients were deﬁned as patients
without relapses in the last year prior to be enrolled in the study Pa-
tients were divided according to disease duration periods: short, up to
1 year from clinical onset, moderate, 1 year and up to 6 years from clin-
ical onset, and long, 6–10 years from clinical onset. Disease durationwas
calculated since the onset of the ﬁrst symptomatology suggestive of MS.
All subjects underwent comprehensive neurological examination and
disability was scored by the Expanded Disability Status Scale (EDSS)
by MS specialist neurologists. Data for age-matched normal healthy
subjects were obtained from the hospital radiology MRI Unit database,
which includes MRI data of healthy volunteers recruited from the local
community and hospital staff. None of the healthy volunteers suffered
from any neurological disease or took central nervous system active
medications. The study protocol was approved by the Medical EthicalReview Committee of Sheba Medical Center, Tel-Hashomer, Israel and
all subjects gave written informed consent.
2.3. MRI acquisition protocol
All subjects underwent the same brain MR imaging protocol, per-
formed on 3.0-T MR scanner (Signa, GE) using high-resolution 8 chan-
nel head coil. Data were obtained using the following sequences:
(1) 3D-FSPGR (1 × 1 × 1 mm voxel, TE = 2 ms, TR = 6 ms), (2) T2-
FSE (slice thickness 2.6 mm, TE = 102 ms, TR = 3500 ms), (3) FLAIR
(slice thickness 2.6 mm, TE = 122 ms, TR = 9502 ms, TI = 2375 ms),
(4) 2D-FSPGR with contrast GD-DTPA (slice thickness 2.6 mm, TE =
2ms, TR=250ms). Axial DTI datawere acquired along 31 independent
directions using a single shot echo-planar imaging sequence, (TE =
76 ms, TR = 14,000 ms, b = 1000 s/mm2, FOV 256 × 256 mm, ma-
trix 128 × 128). Two additional images without diffusion weighting
(b = 0 s/mm2) were acquired. Axial images were acquired by contigu-
ous slices with 2.6mm thickness. The slices were positioned to run par-
allel to a line that joins the anterior commissure–posterior commissure
plane. During image acquisition the same image resolution and the
same localizer were used for T2 Flair and DTI series, to obtain similar
axial slice positions.
2.4. Image analysis and post-processing
Speciﬁcations of the methods for DTI analysis were previously
described in detail (Smith et al., 2007). In brief, DICOM ﬁles of the DTI
acquisition were converted into a single multivolume NIFTI ﬁle (Neuro-
imaging Informatics Technology Initiative ﬁle) and transferred to a
linux-based workstation. Analysis process with FMRIB Software Library
(FSL, http://www.fmrib.ox.ac.uk/fsl) was initiated with eddy-current
correction (compensating for distortions and for simple head motion)
and followed by automatic brain extraction. Diffusion tensors were
then reconstructed by ﬁtting a diffusion tensor model at each voxel of
the diffusion images and FA values were generated. Whole-brain
voxelwise differences between subjects were carried out using TBSS
(Smith et al., 2004; Smith et al., 2006). First, FA data of all subjects
were transformed into 1 × 1 × 1 mm3 MNI152 common space by
means of nonlinear registration. Then, the transformed FA images
were averaged to generate a mean FA image which was subsequently
skeletonized, representing tracts common to all of the subjects. In
order to prevent inclusion of non-skeleton voxels, each subject3s aligned
FAmapwasmapped onto the “mean FA skeleton” using a lower thresh-
old of FA of 0.2 in order to exclude gray matter voxels. The approach of
carefully tuned non-linear registration, followed by a creation of amean
FA skeleton intends to face the cross-subject spatial variability effect
(Douaud et al., 2007). FA valueswere extracted forwhole-brain analysis
and formajorWM tracts according to the ICBM-DTI-81WM labels atlas,
which includes 48 labels created by hand segmentation of a standard-
space average of diffusion MRI tensor maps from 81 healthy subjects
(Oishi et al., 2008). In addition, two ﬁber tracts for the inferior longitu-
dinal fasciculi from the JHU-White Matter Tractography atlas were in-
cluded for greater spatial coverage (Mori et al., 2009).
2.5. Statistical analysis
Region-of-interest (ROI) analysis was performed to initially evaluate
themagnitude of FA decreases within predetermined regions. ROI anal-
ysis was calculated by splitting the 4D post-threshold skeletonized vol-
ume of each subject3s WM tract and repackaging them into group 4D
ﬁles. In order to achieve accurate inference of multiple comparisons
over space, voxelwise analysis was performed by the randomize
permutation algorithm from the FSL library, with 5000 permutations
and a cluster signiﬁcance level of p b 0.05 using threshold-free
cluster enhancement (TFCE) (Keihaninejad et al., 2012). TFCE through
the randomize script in TBSS was utilized to establish the volume of
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level, using the aforementioned atlases. Relationship between FA
and clinical parameters was evaluated by Spearman3s rank correlation
test.3. Results
Ninety RRMS patients, 66 females, mean age ± SE: 37.6 ± 1.0, and
25 healthy controls, 14 females, mean age ± SE: 35.1 ± 2.2 years
were included in this study. As expected, patients in the short disease
duration group were younger and with lower neurological disability
as measured by the EDSS. The rate of patients treated by immunomod-
ulatory drugs (IMDs)was 65.7% in the total sample population, andwas
similar between the disease duration groups. In the short group, 65.4%
were treated with IMDs, and similarly 65.2% and 66.6% were treated in
the moderate and long disease duration groups, respectively. In the
short duration group, 70.6% were treated for more than 3 months,
whereas in the moderate and long disease duration groups, 100% and
91.7% of treated patients, respectively, received IMD treatment for
more than 3 months prior to the MRI examination. These similar rates
of treatment between patients enabled us to compare the impact of
DTI variables between groups. The pertinent demographic information
is shown in Table 1.3.1. Whole-brain mean skeleton FA
Whole-brain mean skeleton FA measurements were signiﬁcantly
decreased in RRMS patients with short disease duration as compared
with healthy controls (0.443 ± 0.023 vs. 0.465 ± 0.023, p b 0.001),
as well as in patients with long disease duration as compared with pa-
tients in the moderate disease duration group (0.427 ± 0.020 vs.
0.443 ± 0.022, p b 0.01), but failed to show signiﬁcant difference in
mean FA values between short and moderate disease duration groups
(p= 0.95), Fig. 1. Correlations of FA values in various ROIs with disease
variables, e.g., disease duration and neurological disability by the EDSS
for the whole group of MS patients are shown in Table 2. Decrease in
FA values correlated with disease duration while no correlations were
found with disability. Graphical presentation of the magnitude of
these FA reductions with disease duration is demonstrated in Fig. 2
and Supplementary Movies 1 and 2.Table 1
Demographic and clinical variables of the studied populations.
Healthy subjects All MS patients
N 25 90
Female/male 14/11 66/24
Age 35.1 ± 2.2 (22.6–58.0) 37.6 ± 1.0
(20.1–68.7)
Disease duration 4.2 ± 0.2
(0.0–9.9)
EDSS 2.0 ± 0.1
(0.0–6.5)
Age at onset 33.4 ± 9.1
(18.8–58.8)
% IMD Tx 65.7
IMD, N (% of treated)
Interferons 36 (61.0)
Glatiramer acetate 12 (20.3)
IVIg 3 (5.1)
Natalizumab 1 (1.7)
IMD Tx duration N 3 months
N (%)
53/59 (89.8)
Clinically stable, N (%)
EDSS = Expanded Disability Status Scale; IMD = immunomodulatory drug; Tx = treatment;3.2. TFCE voxelwise analyses
Additional in-depth voxelwise analyseswith TFCE to accurately con-
trol for multiple comparisons over space are shown in Table 3. The re-
sults strengthen the whole-brain mean skeleton FA ﬁndings. There
were diffuse changes between age-matched healthy subjects and
RRMS patients with short disease, virtually no signiﬁcant change be-
tween short and moderate disease duration groups (0 voxels in every
region), and diffuse areas of changes between long and moderate dis-
ease duration groups. Long and short disease duration groups were
compared in order to demonstrate the magnitude of the widespread
FA reduction. This voxelwise analysis revealed 31% diffuse FA reduction
spanning a skeletal area of 60,784 of 195,350 total voxels in 40 major
WM tracts when comparing healthy controls and the short disease du-
ration group. The point of maximal signiﬁcant difference was observed
in the left inferior longitudinal fasciculus. FA reduction of additional 22%
was shown in 30major WM tracts when comparing the long and mod-
erate duration groups, affecting 42,212 of 192,208 skeletal voxels, with
the point of maximal signiﬁcant difference migrating to the body of the
corpus callosum.
4. Discussion
DTI has proven to be an effective tool for providing a non-invasive
in-vivo investigation into WM tissue alterations unseen through con-
ventional MRI (Yu et al., 2012a).
In our current study,we used a region-of-interest approach to inves-
tigate the temporal nature of injury toWM tracts in RRMSpatients in re-
lation to disease duration. The strengths of our ﬁndings are related to
the robust methodology combining a high-resolution imaging protocol
with both voxelwise and ROI approaches. This approach allowed us to
characterize regional tract damage that occurred in large patient sample
groups with varying disease duration.
We have conﬁrmed the early occurringWMalterations also through
voxelwise analysis, which further established the decrease in FA values
between patients with short, moderate and long disease duration pe-
riods. The diffuse changes throughout the cerebral WM tracts were sig-
niﬁcant even in patients with very short disease duration of less than
one year as compared with age-matched controls. These ﬁndings are
in agreement with previous studies that showed decreased in FA in
MS patients with short disease duration. Raz et al. compared 34 MSMS patients by disease duration groups
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Fig. 1.Mean whole-brain skeletal FA value comparison between study groups.
Table 2
Number of voxels in WM tracts with signiﬁcant reduced FA values between groups.










L cerebral peduncle 331 0 169 380
R cerebral peduncle 342 0 95 354
L cingulum cingulate 238 0 306 414
R cingulum cingulate 288 0 327 322
L cingulum hippocampus 13 0 5 2
R cingulum hippocampus 11 0 10 136
L ant corona radiata 1314 0 822 1122
R ant corona radiata 1199 0 472 895
L post corona radiata 726 0 452 517
R post corona radiata 779 0 508 681
L sup corona radiata 1004 0 747 625
R sup corona radiata 975 0 560 747
Body, corpus callosum 2888 0 2813 3104
Genu, corpus callosum 1211 0 1364 1354
Splenium, corpus callosum 2134 0 1494 2152
L corticospinal tract 0 0 0 88
R corticospinal tract 41 0 0 44
L external capsule 1174 0 562 727
R external capsule 1110 0 509 638
Fornix 124 0 153 158
L inf cerebellar peduncle 0 0 0 122
R inf cerebellar peduncle 0 0 0 102
L ant internal capsule 193 0 0 266
R ant internal capsule 72 0 0 283
L post internal capsule 376 0 108 344
R post internal capsule 117 0 296 519
L retrolenticular internal capsule 686 0 657 630
R retrolenticular internal capsule 617 0 528 567
L medial lemniscus 0 0 0 100
R medial lemniscus 0 0 0 83
Mid cerebellar peduncle 1 0 0 853
Pontine crossing tract 0 0 0 88
L post thalamic/optic radiation 1060 0 990 1042
R post thalamic/optic radiation 1085 0 813 1071
L sagittal striatum 472 0 280 250
R sagittal striatum 543 0 168 362
L stria terminalis 280 0 297 302
R stria terminalis 274 0 226 251
L sup cerebellar peduncle 0 0 0 21
R sup cerebellar peduncle 1 0 0 15
L sup front-occipital fasciculus 83 0 0 27
R sup front-occipital fasciculus 0 0 0 31
L sup longitudinal fasciculus 958 0 648 973
R sup longitudinal fasciculus 1086 0 883 1130
L uncinate fasciculus 53 0 8 39
R uncinate fasciculus 40 0 0 1
L inf longitudinal fasciculus 1768 0 982 1467
R inf longitudinal fasciculus 1167 0 948 1050
There are diffuse changes between controls and short disease group, virtually no change
between short and moderate disease groups (0 voxels in every region), and diffuse
areas of changebetween long andmoderate disease groups. Long and short disease groups
were compared in order to demonstrate the magnitude of the widespread FA reduction.
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healthy controls, identifying and demonstrating widespread changes in
FA, especially in the corticospinal tracts and the corpus callosum (Raz
et al., 2010b). Similarly, we have demonstrated that early FA changes
occurred in the corticospinal tracts and in the corpus callosum; however
the most signiﬁcant change with the onset of disease was observed in
the left inferior longitudinal fasciculus (ILF) that connects the occipital
lobe with the anterior part of the temporal lobe, running laterally and
inferiorly to the optic radiation ﬁbers. The ILF is associated with visual
content organization and the establishment of its emotional signiﬁcance
and plays an important role in social tasks requiring recognition of face
emotion expression (Kleinhans et al., 2008). Sensory deﬁcits are typical
of MS at onset and we have previously shown the occurrence of cortical
thinning of several sensory-related regions in the early disease stage
(Achiron et al., 2013b). As the ILF is known to be associated with visual
comprehension and visualmemory (Chanraud et al., 2010), our ﬁndings
suggest that the impairment in its structural integritymay affect the ca-
pacity of MS patients to appropriately and in-time comprehend visual
cues, even if no signiﬁcant neurological disability is demonstrated. Dis-
ruption of the ILF was already reported to occur in MS patients with av-
erage disease duration of 3.6 years (Roosendaal et al., 2009). Our results
show that not only are these changes the most signiﬁcant among the
WMalterations, but that they also occur earlier than previously reported.
Further comparison of RRMS patients with short disease duration
(up to 1 year) with the moderate disease duration (between 1 and
6 years) showed no signiﬁcant differences between WM skeletons on
both whole-brain skeletal FA measurements and in-depth TFCE
voxelwise analyses. The ﬁnding that short and moderate disease dura-
tion groups did not show any FA differences is of interest. This suggests
that WM disruption reaches a plateau during this 5 year interval. Simi-
larly, changes in FA were not detected over a period of a 1 year follow-
up in clinically-isolated MS patients (Raz et al., 2010b), and no signiﬁ-
cant FA changeswere identiﬁed over time in RRMS patients by repeated
MRI scans within 5 years from onset (Giorgio et al., 2010). This may be
related to the concept of “brain reserve,” whereby the disease-induced
insult is not signiﬁcant enough to result in structural changes within
the WM tracts, reﬂecting the capacity to withstand deteriorating pro-
cesses and the ability to endure or recover quickly from the insult. The
idea of this reserve against brain damage stems from repeated observa-
tions showing no apparent relationship between the degree of brain pa-
thology or damage and the clinical manifestations of that damage
(Stern, 2002). In both the early and moderate disease duration groups,
patients bear greater capacity to withstand acquired white matter in-
sults. Related to this observation, a recent study reported that both pa-
tients with radiologically-isolated syndrome (RIS) and relapsing–
remittingMS had altered integrity ofWM tracts as compared to normal
matched controls. However, in measuring WM tract integrity, RIS
patients lacked functional reorganization in key brain networks,suggesting a model of “functional reserve”which may become upregu-
lated, with an adaptive or maladaptive role, only at a later stage.
(Giorgio et al., 2015)
In contrast, the comparison between the moderate (1–6 years) and
the long disease duration (6–10 years) groups showed diffuse and sig-
niﬁcant changes involving almost all major WM tracts, with FA reduc-
tion of 22% affecting 42,212 of 192,208 skeletal voxels, with the point
of maximal signiﬁcant difference migrating from the ILF to the body of
the corpus callosum which is widely known to be involved in MS. Ac-
cordingly, FA reductions appear to exhibit a non-linear time course
with two “accelerations”. An acute, diffuse WM change within the ﬁrst
year following the initial clinical event, and another more gradual de-
cline occurred as the disease approaches the 10-yearmark. We hypoth-
esize that in the early stage, the sharp decline in FA relates to diffuse
alterations in the normal-appearing WM, whereas the more gradual
Fig. 2. Comparison of FA differences inWM tracts between healthy subjects and MS patients according to disease duration. Signiﬁcant clusters of reduced FA (p b 0.05) are shown in red
(axial) andorange (3-dimensional) overlaid on a template imagebrain. A, C, Comparison betweenhealthy subjects andMSpatientswith short disease duration (b1 year). B, D, Comparison
between healthy subjects and MS patients with long disease duration (N6 years).
265A. Asaf et al. / NeuroImage: Clinical 8 (2015) 261–266decrease over a longer disease duration relates to subsequentWallerian
degeneration and axonal disruption. This progression signiﬁes a point-
of-no-return, whereby the accumulating WM damage spreads expo-
nentially and therefore makes the ﬁrst 6 years an important time-
frame for immunomodulatory drug treatment. This possibility of a ther-
apeutic window stands for the period of time following MS onset
whereby early treatment may favorably affect long-term disease out-
come, and has been also suggested by the results of our previous
study where we demonstrated that cognitive impairment in MSTable 3
Correlation between FA values in various ROIs with MS disease related variables.
ROI Disease duration Age
Fornix r = −0.31 p = 0.002 r = −0.24 p = 0.02
L cerebral peduncle r = −0.29 p = 0.004 r = −0.20 p = 0.05
R cerebral peduncle r = −0.30 p = 0.03 r = −0.24 p = 0.02
Genu, corpus callosum r = −0.23 p = 0.023
Splenium, corpus callosum r = −0.31 p = 0.003
R corticospinal tract r = −0.44 p = 0.000
R medial lemniscus r = −0.24 p = 0.021
L medial lemniscus r = −0.31 p = 0.003
R inf cerebellar peduncle r = −0.34 p = 0.001
R pos internal capsule r = −0.26 p = 0.013
L pos internal capsule r = −0.23 p = 0.031
L sup corona radiata r = −0.27 p = 0.01
R sup corona radiata r = −0.24 p = 0.021
L pos corona radiata r = −0.28 p = 0.007
L pos thalamic/optic radiation r = −0.26 p = 0.01
R pos thalamic/optic radiation r = −0.30 p = 0.003
R sup long fasciculus r = −0.25 p = 0.01
R tapetum r = −0.34 p = 0.001
L tapetum r = −0.35 p = 0.001
EDSS did not correlate with any WM tract.
ROI = region of interest; FA = fractional anisotropy; EDSS = Expanded Disability Status
Scale; R = right; L = left; inf = inferior; pos = posterior; sup = superior.patients was signiﬁcant only at disease duration greater than 5 years
(Achiron et al., 2013a).
Other studies also reportedDTI changes in RRMSpatientswithin this
time-frame. Roosendaal et al. (2009), studying regional DTI differences
in 30 RRMS patients with a mean disease duration of 3.6 years as com-
pared with 31 age-matched controls, demonstrated FA decrease in var-
ious brain regions including the fornices, the left corona radiata, the
inferior longitudinal fasciculus in both hemispheres, both optic radia-
tions, and parts of the corpus callosum; Giorgio et al. (2010) used
TBSS cross-sectional analysis in 45 RRMS patients with 3 years of dis-
ease duration and demonstrated decreased FA in the splenium of the
corpus callosum and along the pyramidal tract; Kern et al. (2011) eval-
uated 25MS patients with a mean disease duration of 4.8 years in com-
parison to 16 controls and demonstrated a decrease in FA in the
transcallosal hand motor ﬁbers and corticospinal tracts.
The therapeutic window opportunity is further intensiﬁed by the
fact that theWMdamage accumulatesmicroscopically but is not appar-
ent clinically, as we did not ﬁnd correlation with neurological disability.
This is in accordance with previous study that also did not ﬁnd correla-
tions between mean FA values and EDSS (Raz et al., 2010a).
Some limitations apply to this work. First, the cross-sectional
nature of the study limited our ability to monitor the evolution of WM
distraction on an individual basis. A longitudinal study will enable
us to verify the results by following the same patients overtime.
Second, we had relatively small sample size particularly for the long
(6–10 years) disease duration group, and thirdwewere not able to syn-
chronize the MRI data to different IMDs3 treatment history and current
treatment regimens and thus we did not analyze potential medication
effects on WM pathology. This was related to the diversity in the type
of treatment (e.g., different IMDs), difference in treatment duration
(e.g., different time-frames for each IMD) and treatment sequence
order (e.g., difference in the choice of the ﬁrst, second and third lines
of IMD).
266 A. Asaf et al. / NeuroImage: Clinical 8 (2015) 261–266It is of importance tomention thatwehave focused on global aspects
of the microstructural WM damage in patients with varying periods of
disease duration future studies will need to focus onmore homogenous
groups of patients to identify local properties of WM damage over time
aswell as to examine other diffusionmetrics such as axial and radial dif-
fusivities that may add additional useful information about the processes
occurring in MS.
In conclusion, utilizingDTIwith TBSS analyses, we have demonstrat-
ed the occurrence of widespread injury to WM tracts in RRMS patients.
Wehave subsequently shown that this structural damage appears in the
very early stage of the diseasewith less than a year fromonset. These al-
terations reach a plateau within the next 5 years, and only later as the
pathological process accumulates, additionalWM changes are detected.
An important therapeutic window therefore exists within the early dis-
ease stage.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.nicl.2015.04.020.
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